Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huihe Medical
Shanghai, Shanghai, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Huihe Medical has developed the K‑Clip annuloplasty system, a minimally invasive transcatheter device designed to treat severe tricuspid regurgitation. In first-in-human studies of the K‑Clip involving patients with severe TR, procedural success was reported at 100% with no major adverse cardiovascular events at one month. Echocardiography showed significant reductions in annular circumference and area, and patient quality-of-life scores improved markedly. Larger studies and longer-term follow-up are needed before widespread adoption.
- Therapeutic areas
- OncologyCardiovascular
- Modalities
- DeviceInterventional medical deviceTranscatheter heart valve repair system
- Industry
- Surgical Medical Devices
Beyond the preview
Go deeper on Huihe Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Huihe Medical.